Rancho Santa Fe, CA, United States of America

Dale E Bredesen

This inventor holds 8 USPTO granted patents, plus 4 CIPO patents. Top assignees: University of California, The Burnham Institute. Active years: 1994-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dale E Bredesen. Retrieved from https://idiyas.com/inventor/dale-e-bredesen-1ir4913j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 1.3

ph-index = 3

Forward Citations = 35(Granted Patents)

Location History:

Los Angeles, CA (US) (1994)
Palos Verdes Estates, CA (US) (1996 - 1997)
Rancho Santa Fe, CA (US) (1997 - 2003)

Company Filing History:

7 out of 16,035

University of California

patents

2 out of 94

The Burnham Institute

patents

where one patent can have more than one assignee

Years Active: 1994-2003

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6649364 - Anti-apoptotic compositions and methods using same (2003-11-18),

2. 6235872 - Proapoptotic peptides dependence polypeptides and methods of use (2001-05-22),

3. 6231852 - Method for reducing BCL-2 expressing cells resistance to death (2001-05-15),

4. 5834457 - Method of modulating radical formation by mutant cuznsod enzymes (1998-11-10),

5. 5681711 - Method for promoting apoptosis in mammalian neual cells (1997-10-28),

6. 5677135 - Method for increasing the resistance of neural cells to .beta.amyloid (1997-10-14),

7. 5576209 - Method for increasing the resistance of neural cells to .beta.-amyloid (1996-11-19),

8. 5324654 - Method for reversibly increasing proliferation of a non-malignant cell (1994-06-28),

Title: Dale E Bredesen: Innovator in Anti-Apoptotic Research

Introduction

Dale E Bredesen is a prominent inventor based in Rancho Santa Fe, California. He has made significant contributions to the field of biomedical research, particularly in the area of anti-apoptotic compositions. With a total of eight patents to his name, Bredesen's work has the potential to impact various therapeutic approaches.

Latest Patents

Among his latest patents, Bredesen has developed anti-apoptotic compositions and methods utilizing pro-apoptotic peptides. His inventions provide substantially pure pro-apoptotic dependence peptides, which consist of sequences from various dependence polypeptides. Notable sequences include SATLDALLAALRRI, Q14, SATLDALLAALGGI, SATLDALLAALRGI, SATLQALLAALRRI, tat-GG-SATLDALLAALRRI, and tat-GG-Q14.

Career Highlights

Bredesen has had a distinguished career, working with esteemed institutions such as the University of California and the Burnham Institute. His research has focused on understanding the mechanisms of cell death and developing innovative solutions to combat related diseases.

Collaborations

Throughout his career, Bredesen has collaborated with notable colleagues, including Joan S Valentine and Martina Wiedau-Pazos. These partnerships have contributed to the advancement of his research and the development of his patents.

Conclusion

Dale E Bredesen is a key figure in the field of anti-apoptotic research, with a strong portfolio of patents that reflect his innovative contributions. His work continues to pave the way for new therapeutic strategies in medicine.

Profile summary based on public USPTO records.